Aardvark Therapeutics, Inc. AARD
Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2025-02-13
Aardvark Therapeutics, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| CITADEL ADVISORS LLC | 1,342,266 | $7.7M | 6.15% |
| AQR CAPITAL MANAGEMENT LLC | 480,249 | $2.8M | 2.2% |
| TWO SIGMA INVESTMENTS, LP | 108,377 | $624,252 | 0.5% |
| MILLENNIUM MANAGEMENT LLC | 69,948 | $402,900 | 0.32% |
| Point72 Asset Management, L.P. | 22,872 | $131,743 | 0.1% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.